Publikationen in Zusammenarbeit mit Forschern von French Institute of Health and Medical Research (25)

2021

  1. 2-phenoxy-3-trichloromethylquinoxalines are antiplasmodial derivatives with activity against the apicoplast of plasmodium falciparum

    Pharmaceuticals, Vol. 14, Núm. 8

2019

  1. Evaluation of a non-parametric modelling for meropenem in critically ill patients using Monte Carlo simulation

    European Journal of Clinical Pharmacology, Vol. 75, Núm. 10, pp. 1405-1414

2017

  1. Model description language (MDL): A standard for modeling and simulation

    CPT: Pharmacometrics and Systems Pharmacology, Vol. 6, Núm. 10, pp. 647-650

2015

  1. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLoS Medicine, Vol. 12, Núm. 3

  2. Modulation of intestinal L-glutamate transport by luminal leptin

    Journal of Physiology and Biochemistry, Vol. 71, Núm. 2, pp. 311-317

  3. α-Lipoic acid treatment increases mitochondrial biogenesis and promotes beige adipose features in subcutaneous adipocytes from overweight/obese subjects

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1851, Núm. 3, pp. 273-281

2014

  1. Conventional but not plasmacytoid dendritic cells foster the systemic virus-induced type I IFN response needed for efficient CD8 T cell priming

    Journal of Immunology, Vol. 193, Núm. 3, pp. 1151-1161

  2. α-Lipoic acid reduces fatty acid esterification and lipogenesis in adipocytes from overweight/obese subjects

    Obesity, Vol. 22, Núm. 10, pp. 2210-2215

2013

  1. Usage of Adenovirus Expressing Thymidine Kinase Mediated Hepatocellular Damage for Enabling Mouse Liver Repopulation with Allogenic or Xenogenic Hepatocytes

    PLoS ONE, Vol. 8, Núm. 9

2012

  1. Brain drug delivery systems for neurodegenerative disorders

    Current Pharmaceutical Biotechnology, Vol. 13, Núm. 12, pp. 2388-2402

2011

  1. Altered expression of neuronal tryptophan hydroxylase-2 mRNA in the dorsal and median raphe nuclei of three genetically modified mouse models relevant to depression and anxiety

    Journal of Chemical Neuroanatomy, Vol. 41, Núm. 4, pp. 227-233

  2. Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10

    Hepatology, Vol. 53, Núm. 1, pp. 23-31

  3. Neuroprotective properties of marrow-isolated adult multilineage-inducible cells in rat hippocampus following global cerebral ischemia are enhanced when complexed to biomimetic microcarriers

    Journal of Neurochemistry, Vol. 119, Núm. 5, pp. 972-988

  4. The therapeutic potential of human multipotent mesenchymal stromal cells combined with pharmacologically active microcarriers transplanted in hemi-parkinsonian rats

    Biomaterials, Vol. 32, Núm. 6, pp. 1560-1573

2010

  1. Chronic benzylamine administration in the drinking water improves glucose tolerance, reduces body weight gain and circulating cholesterol in high-fat diet-fed mice

    Pharmacological Research, Vol. 61, Núm. 4, pp. 355-363

  2. Tumor therapy in mice by using a tumor antigen linked to modulin peptides from Staphylococcus epidermidis

    Vaccine, Vol. 28, Núm. 44, pp. 7146-7154

2008

  1. Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes

    Bioconjugate Chemistry, Vol. 19, Núm. 12, pp. 2385-2393

2007

  1. Expanding role for the apelin/APJ system in physiopathology

    Journal of Physiology and Biochemistry

  2. Influence of acute and chronic administration of benzylamine on glucose tolerance in diabetic and obese mice fed on very high-fat diet

    Journal of Physiology and Biochemistry, Vol. 63, Núm. 4, pp. 305-315

2005

  1. Albumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs

    Mini-Reviews in Medicinal Chemistry, Vol. 5, Núm. 3, pp. 293-305